Phenethylamine
An endogenous trace amine that's structurally amphetamine-like and marketed as a mood / energy / pre-workout supplement. Oral PEA is destroyed by MAO-B within minutes, so monotherapy capsules deliver brief, mild sympathomimetic effects at best. The classic mood-supporting studies all combined PEA with a prescription MAO-B inhibitor.
Quick decision guide
May help most
Curious users who want a brief stimulant-style 'flush' before exercise — not a reliable mood treatment.
Common dosing range
100–500 mg per dose in supplements. Effect, if perceptible, lasts only minutes.
When to expect effects
Onset 15–30 min; effect dissipates within an hour.
Watch out for
Do not combine with MAOIs (including selegiline, rasagiline, linezolid) — risk of hypertensive crisis. PEA monotherapy is not a substitute for depression treatment.
Evidence snapshot
What is it
Phenethylamine (PEA, beta-phenylethylamine) is a naturally occurring trace amine produced in the brain and present in small amounts in foods like chocolate. It is structurally similar to amphetamine and serves as a neuromodulator affecting mood and arousal. Supplemental phenethylamine is sold for energy, mood, and focus.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Brief energy and focus 'flush' Mixed Evidence | Short, mild, inconsistent stimulant effect — not quantified in controlled trials | Healthy adults experimenting with a short-acting stimulant supplement | 15–30 minutes; dissipates within ~60 min |
Depression (combined with MAO-B inhibitor only) Mixed Evidence | Response in 60% of treatment-resistant patients in an open trial — not placebo-controlled | Treatment-resistant depression under specialist psychiatric care — and only with prescription MAOI co-therapy | Days to weeks in the open trials, when combined with selegiline |
Cognition, attention, motivation Mixed Evidence | Not quantified in human RCTs | No identified population | Not established |
Brief energy and focus 'flush'
- Effect
- Short, mild, inconsistent stimulant effect — not quantified in controlled trials
- Best fit
- Healthy adults experimenting with a short-acting stimulant supplement
- Time
- 15–30 minutes; dissipates within ~60 min
Depression (combined with MAO-B inhibitor only)
- Effect
- Response in 60% of treatment-resistant patients in an open trial — not placebo-controlled
- Best fit
- Treatment-resistant depression under specialist psychiatric care — and only with prescription MAOI co-therapy
- Time
- Days to weeks in the open trials, when combined with selegiline
Cognition, attention, motivation
- Effect
- Not quantified in human RCTs
- Best fit
- No identified population
- Time
- Not established
Evidence for 3 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Brief energy and focus 'flush'
Mechanism onlyMost subjective reports from oral PEA describe a 10–30 minute burst of stimulation, mild euphoria, and energy — qualitatively similar to but much weaker and shorter than amphetamine. This is consistent with rapid release and even more rapid MAO-B clearance. There are no controlled human trials of PEA monotherapy for energy, focus, or athletic performance.
Bottom line: Real-but-brief mild stimulant effect, no clinical validation; placebo plays a non-trivial role.
Depression (combined with MAO-B inhibitor only)
Disease adjunctSabelli's 1986 open trial and 1996 replication reported sustained antidepressant response when PEA (10–60 to 100–500 mg/day) was combined with the prescription MAO-B inhibitor selegiline. PEA alone, without an MAOI, was explicitly described as ineffective in this work because of its 5–10 minute plasma half-life. The trials were open-label (no placebo control), small, and have not been replicated by independent groups in a modern randomised design.
Bottom line: The 'PEA-for-depression' marketing rests on data that required a prescription MAOI. Don't self-treat depression with PEA.
Evidence is mixed
All positive depression data require an MAOI co-prescription. OTC PEA monotherapy is biologically incapable of sustaining the CNS levels seen in those trials — marketing claims to the contrary mislead consumers.
Cognition, attention, motivation
Mechanism onlyTAAR1 agonism by PEA modulates dopamine and norepinephrine in animal models — the same neurotransmitter systems targeted by ADHD medications. Translating this to a reliable, durable human cognitive benefit is blocked by oral PEA's pharmacokinetics. No RCTs support PEA monotherapy for ADHD, attention, or learning.
Bottom line: Plausible mechanism, no human evidence.
How it works
How to take it
What to track
Bottom line: Start at 100 mg, on an empty stomach, well before any planned activity. Expect a short, mild, inconsistent effect. Never combine with an MAOI.
4 commercial forms
Compare the main delivery options and what they’re best suited for.
Phenethylamine HCl capsules
StandardThe most common consumer form. Salt is more stable and easier to dose than free-base PEA. Effect remains brief due to MAO-B metabolism.
Oral half-life 5–10 min; minimal sustained CNS exposure without an MAOI.
PEA + hordenine 'extender' stacks
Pharmacologically dubiousHordenine has weak MAO-B-inhibitory activity in vitro but human evidence that it meaningfully prolongs PEA's effect is essentially absent. Marketed widely; not pharmacokinetically validated.
Theoretical extension of PEA half-life; not demonstrated in humans.
PEA + selegiline (prescription only)
Trial protocolThe combination used in the Sabelli depression trials. Requires a psychiatric prescription for selegiline. Carries genuine MAOI-class dietary and drug-interaction risks.
Selegiline blocks MAO-B, restoring meaningful sustained CNS PEA exposure.
Beta-methyl-phenethylamine (BMPEA) and other analogues
Not the sameBMPEA is a separate synthetic compound (methyl-substituted), once found adulterating 'Acacia rigidula' weight-loss supplements. The FDA has issued warning letters. Don't confuse it with PEA or assume the same evidence base.
Different pharmacology; not interchangeable with PEA.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Hypertensive crisis when combined with any monoamine oxidase inhibitor — selegiline, rasagiline, phenelzine, tranylcypromine, isocarboxazid, and linezolid (an antibiotic that's also a weak MAOI). The MAOI removes PEA's main metabolic brake, producing dangerous sympathomimetic surges.
Potential serotonin / adrenergic overload when combined with SSRIs, SNRIs, MDMA-class drugs, ADHD stimulants, or other sympathomimetics.
Migraine triggering — PEA is a known dietary migraine trigger (the same trace amine in 'aged-cheese / chocolate / red wine' triggers).
Mania or psychosis precipitation in people with bipolar disorder or psychotic-spectrum conditions — dopaminergic surge can destabilise these conditions.
Who should avoid it
- Anyone taking any MAOI (selegiline, rasagiline, phenelzine, tranylcypromine, isocarboxazid, moclobemide, linezolid) — risk of hypertensive crisis.
- People with hypertension, arrhythmia, coronary disease, or any history of stroke / TIA.
- People with anxiety disorders, bipolar disorder, psychotic disorders, or migraine.
- Anyone pregnant, breastfeeding, or under 18 — no safety data.
- Athletes subject to anti-doping (NCAA, WADA) — PEA itself is monitored as a stimulant; check current banned-substances lists before competition.
Pregnancy & breastfeeding
Avoid in pregnancy and while breastfeeding. PEA crosses the blood-brain barrier and the placenta; no pregnancy safety data exist, and its sympathomimetic profile is unsuitable for use during pregnancy.
Bottom line: The biggest safety story is the catastrophic interaction with MAOIs. The everyday issue is that oral PEA does very little reliably; expecting more invites overdosing.
Interactions
MAO-B is the primary clearance enzyme for PEA. Blocking it dramatically increases CNS and peripheral PEA levels, with hypertensive crisis and serotonin-style reactions reported.
Even greater clearance impairment than selective MAO-B inhibitors — risk of hypertensive crisis is highest with this class.
Linezolid has weak but clinically significant MAO inhibition — combining with PEA carries the same crisis risk as a dedicated MAOI.
Additive monoamine release — increased risk of serotonin syndrome, hypertension, and anxiety.
Additive sympathomimetic and dopaminergic load — cardiovascular and anxiety risks compound.
PEA's pressor effect can transiently counteract blood-pressure-lowering therapy.
Additive heart rate / blood pressure / anxiety effects.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Chocolate (dark, cocoa-rich) | 1 oz (~2 mg PEA) | — |
| Aged cheeses (cheddar, parmesan) | 1 oz (trace amounts) | — |
| Fermented foods (sauerkraut, kimchi) | 1 cup (trace amounts) | — |
| Red wine | 5 oz (trace amounts) | — |
| Cured meats (salami, sausage) | 1 oz (trace amounts) | — |
Chocolate (dark, cocoa-rich)
- Amount
- 1 oz (~2 mg PEA)
- %DV
- —
Aged cheeses (cheddar, parmesan)
- Amount
- 1 oz (trace amounts)
- %DV
- —
Fermented foods (sauerkraut, kimchi)
- Amount
- 1 cup (trace amounts)
- %DV
- —
Red wine
- Amount
- 5 oz (trace amounts)
- %DV
- —
Cured meats (salami, sausage)
- Amount
- 1 oz (trace amounts)
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is the PEA in chocolate the same as in supplements?⌄
Yes, the molecule is identical. However, food sources provide very small amounts that are largely metabolized in the gut. Supplements deliver higher doses but still face rapid breakdown.
Does PEA actually work in supplements?⌄
Effects of oral PEA alone are limited by rapid metabolism. Combinations with MAO inhibitors may have more noticeable effects, with greater safety concerns.
Why do I feel good after chocolate?⌄
Often attributed to PEA, but the small amounts in chocolate are unlikely to produce significant central effects. Other compounds in chocolate (theobromine, caffeine, sugar, fats) and the sensory experience itself contribute more.
Is PEA banned in sports?⌄
PEA and several of its analogs are monitored by anti-doping agencies; some are banned. Athletes should consult their governing body's prohibited list.
Can I take PEA with antidepressants?⌄
No. Combining PEA (or related compounds) with SSRIs, SNRIs, or MAOIs carries serious risks of serotonin syndrome or hypertensive crisis. Consult a clinician before any combination.
References by claim
Depression (combined with MAO-B inhibitor only)
Brief energy and focus 'flush'
Track Phenethylamine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.